Last $20.99 USD
Change Today -0.18 / -0.85%
Volume 1.3M
MASI On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Marketwire  07/29/2014 2:00 AM ET
Masimo Announces CE Mark and Limited Market Release of Radius-7(TM) -- First rainbow(R) SET(R) Noninvasive Wearable, Wireless Monitor for Root(R)

NEUCHATEL, SWITZERLAND -- (Marketwired) -- 07/29/14 -- Masimo (NASDAQ: MASI) today announced CE Mark and limited market release of Radius-7™ for the Root patient monitoring and connectivity platform, the first and only wearable, wireless monitor with Masimo's breakthrough rainbow™ SET™ technology, enabling early identification of clinical deterioration while offering patients continuous monitoring with freedom of movement.

See Radius-7 Video

With rainbow™ SET™ noninvasive measurements, Radius-7 with Root can alert clinicians -- at the bedside or remotely, through the Masimo Patient SafetyNet™ remote monitoring and notification system -- of critical changes in a patient's oxygen saturation, pulse rate, respiration rate, or haemoglobin that may indicate pulmonary, cardiac, or internal bleeding problems. Lightweight at only 155g (0.34 lbs), the Radius-7 attaches to the patient's arm or can be placed alongside the patient in their bed, allowing untethered monitoring while they are in bed or out. With no need to disconnect and reconnect the cable to get out of bed, the Radius-7 reduces the need for nursing assistance. And the Radius-7's wireless communication functionality -- either short-range via Bluetooth back to Root or with upgradeable WiFi for long-range communication* -- ensures the patient can be continuously monitored and connected to caregivers wherever they are in the hospital.

Studies have shown that patient mobility is a key factor in more rapid patient recovery.(1) Radius-7 allows clinicians to mobilize their patients.

"With this new technology we have made another important step to improve patient safety," said Caroline Stade, chief nursing officer at University Children's Hospital Basel (UKBB) in Basel, Switzerland. "Children can be cared for and move about as they are able, while remaining under seamless, clinical surveillance. This makes parents, and of course, nurses and clinicians, feel better about the quality of care offered to our pediatric patients."

"In the past, wearable patient monitoring offered only limited measurements that were often plagued by false alarms. Radius-7 allows untethered clinically relevant patient monitoring," said Masimo founder and CEO Joe Kiani. "We expect Radius-7 and Root to change how hospitals think about monitoring, ushering in a new level of patient safety."

Radius-7 is not available for sale in the United States.

*The configuration for long-range communication is pending CE marking.

1 Needham D, Korupolu R, Zanni J, Pradhan P, Colantuoni E, Palmer J, Brower R, Fan E. "Early Physical Medicine and Rehabilitation for Patients With Acute Respiratory Failure: A Quality Improvement Project." Archives of Physical Medicine and Rehabilitation Vol 91, Issue 4, PP 536-542, April 2010

About Masimo
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care -- helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET™, which virtually eliminated false alarms and increased pulse oximetry's ability to help clinicians detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET™ outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient mot

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MASI:US $20.99 USD -0.18

Industry News

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MASIMO CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.